je.st
news
Ubs Ag Increases Mylan Price Target to $39.00
2013-08-03 08:58:32| Biotech - Topix.net
The firm currently has a "buy" rating on the stock. UBS AG's target price would suggest a potential upside of 7.14% from the company's current price.
Tags: price
target
increases
ubs
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||